Multiclinic controlled trial of bethanidine and guanethidine in severe hypertension. 1977

E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas

One hundred and eight patients with initial diastolic blood pressure in the range of 100-124 mm Hg while taking hydrochlorothiazide were assigned randomly and double-blind to hydrochlorothiazide plus either bethanidine or guanethidine. The average reduction of the fifth and sixth months' diastolic blood pressure was 18.4 mm Hg for guanethidine and 13.6 mm Hg for bethanidine (P less than 0.01). The distribution of the individual values was such that 68.8% of guanethidine treated patients achieved a diastolic level below 90 mm Hg, compared to only 45.5% of the bethanidine treated group (P less than 0.025). The degree of orthostatic fall in blood pressure was greater with bethanidine than with guanethidine (P less than 0.05). The diurnal variation of blood pressure was slightly greater with bethanidine than with guanethidine. The results significantly favor guanethidine. This study failed to demonstrate that the shorter action of bethanidine confers significantly better control of blood pressure than the longer action of guanethidine.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006145 Guanethidine An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. ((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine,Guanethidine Monosulfate,Guanethidine Sulfate,Guanethidine Sulfate (1:1),Guanethidine Sulfate (1:2),Guanethidine Sulfate (2:1),Guanethidine Sulfate (2:1), 14C-Labeled,Ismelin,Isobarin,Octadine,Oktadin,Monosulfate, Guanethidine,Sulfate, Guanethidine
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006852 Hydrochlorothiazide A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. Dichlothiazide,Dihydrochlorothiazide,Esidrex,Esidrix,HCTZ,HydroDIURIL,Hypothiazide,Oretic,Sectrazide
D001627 Bethanidine A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear. Batel,Betanidine,Bethanidine Sulfate,Bethanidine, Sulfate (2:1),Sulfate, Bethanidine
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
May 1975, British medical journal,
E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
March 1969, American heart journal,
E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
April 1978, Circulation,
E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
January 1966, The Medical journal of Australia,
E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
January 1968, British medical journal,
E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
November 1974, Current therapeutic research, clinical and experimental,
E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
August 1969, Minnesota medicine,
E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
November 1965, Archives internationales de pharmacodynamie et de therapie,
E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
January 1968, British medical journal,
E A Ramirez, and L Elson, and A S Gear, and J R Oster, and F N Talmers, and J R Thomas
February 1982, The American journal of medicine,
Copied contents to your clipboard!